Treace Medical Concepts I... (TMCI)
Company Description
Treace Medical Concepts, Inc., an orthopedic medical device company, engages in the design, manufacture, and marketing of medical devices for foot and ankle surgeons in the United States.
It offers Lapiplasty procedure that allows podiatric surgeons to treat all three dimensions of the bunion, providing patients with a cosmetic and medical improvement.
The company also provides Lapiplasty Mini-Incision precision system.
In addition, it offers products to address ancillary surgical procedures, including akin osteotomies, weil osteotomies, intercuneiform stabilization, lesser tarsometatarsal joint fusions, and autograft bone harvesting, as well as for MTP fusion.
Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra Beach, Florida.

Country | United States |
IPO Date | Apr 23, 2021 |
Industry | Medical - Devices |
Sector | Healthcare |
Employees | 477 |
CEO | John T. Treace |
Contact Details
Address: 203 Fort Wade Road Ponte Vedra, Florida United States | |
Website | https://www.treace.com |
Stock Details
Ticker Symbol | TMCI |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001630627 |
CUSIP Number | 89455T109 |
ISIN Number | US89455T1097 |
Employer ID | 47-1052611 |
SIC Code | 3841 |
Key Executives
Name | Position |
---|---|
John T. Treace | Chief Executive Officer, Founder & Director |
Mark L. Hair CPA | Chief Financial Officer |
Aaron J. Berutti | Senior Vice President of Sales |
Daniel E. Owens | Chief Human Resources Officer |
Dr. Sean F. Scanlan Ph.D. | Chief Innovation Officer |
Gaetano M. Guglielmino | Chief Commercial Officer |
Scot M. Elder J.D. | Chief Legal & Compliance Officer and Corporate Secretary |
Shana Zink | Senior Vice President of Clinical Affairs & Reimbursement |
Taylor Erickson | Chief Information & Cybersecurity Officer |
Terry W. Lubben | Chief Operations & Supply Chain Officer |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Apr 07, 2025 | DEF 14A | Filing |
Apr 07, 2025 | ARS | Filing |
Apr 07, 2025 | 8-K | Current Report |
Apr 07, 2025 | DEFA14A | Filing |
Mar 19, 2025 | 4 | Filing |
Mar 11, 2025 | 4 | Filing |
Mar 11, 2025 | 4 | Filing |
Mar 11, 2025 | 4 | Filing |
Mar 11, 2025 | 4 | Filing |
Mar 11, 2025 | 4 | Filing |